CH is the pre-malignant lesion that precedes hematologic malignancy, including both mutations in myeloid driver genes (CHIP) [1–3] and somatic copy number variants (mosaic chromosomal alterations, mCAs) [4–6]. This evidence concerns the gene STUB1 and cyclic hematopoiesis.